News
News
- Exagen Inc. Partners with Boston’s Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases
01/21/2021 / 22:05 - GlobeNewswire - Minerals Technologies Announces Fourth Quarter 2020 Conference Call
01/18/2021 / 14:41 - GlobeNewswire - Minerals Technologies Announces Price Increase for Specialty Minerals Products in U.S.
01/14/2021 / 22:30 - GlobeNewswire - Exagen Inc. Partners with Oregon’s St. Charles Health System to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases
01/04/2021 / 22:05 - GlobeNewswire - Gilead and Galapagos announce New Commercialization and Development Agreement for Jyseleca® (filgotinib)
12/15/2020 / 22:15 - GlobeNewswire - Minerals Technologies Statement Regarding Elementis plc (“Elementis” or “the Company”)
12/10/2020 / 13:00 - GlobeNewswire - Minerals Technologies Announcement Regarding Elementis plc (“Elementis”)
11/25/2020 / 13:00 - GlobeNewswire - Minerals Technologies Announcement Regarding Elementis plc (“Elementis”)
11/12/2020 / 13:00 - GlobeNewswire - EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF ULCERATIVE COLITIS
11/02/2020 / 22:01 - GlobeNewswire - Minerals Technologies Reports Third Quarter 2020 Earnings of $0.83 Per Share, or $0.92 Per Share, Excluding Special Items
10/29/2020 / 22:01 - GlobeNewswire
Real-time